Pioneer Surgical Technology announced the successful European human implantation of its new interbody spacer.
The nanOss cervical cage is machined from robust nanocrystalline hydroxyapatite (HA) and is used for the treatment of cervical disc disease. The surgeries were performed at hospitals in the United Kingdom and are the first expansion of Pioneer’s Biologics products into Europe.
Shane Ray, general manager Biologics, Pioneer Surgical Technology, said, “We are very pleased to expand our interbody product offerings into Europe with nanOss Cervical and to utilise the alliance with our sales, technical, and support team in Europe. This novel product is the first of its kind composed of hydroxyapatite to provide strength as a cervical spacer. We look forward to expanded sales of nanOss Cervical throughout key markets within and outside Europe.”